Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 93, Issue 6, 2008, Pages

  Finken, Martijn J J ^a   Keijzer Veen, M G ^a,b   Dekker, F W ^a   Frolich M ^a   Walther, F J ^a   Romijn, J A ^a   Van Der Heijden, B J ^b   Wit, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLISM; PREMATURITY; PRENATAL CARE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SIDE EFFECT; SMALL FOR DATE INFANT;

BETAMETHASONE; BLOOD PRESSURE; BODY COMPOSITION; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; GLOMERULAR FILTRATION RATE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INSULIN RESISTANCE; LIPIDS; MALE; PREGNANCY; PRENATAL CARE; PRENATAL EXPOSURE DELAYED EFFECTS; YOUNG ADULT;

EID: 55349118840     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2007.128470     Document Type: Article

References (35)

1. Stoelhorst GM, Rijken M, Martens SE, et al. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project On Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997. Pediatrics 2005;115:396-406.
2. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal long maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;3:CD004454.
3. Benediktsson R, Lindsay RS, Noble J, et al. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993;341:339-41.
4. Martins JP, Monteiro JC, Paixao AD. Renal function in adult rats subjected to prenatal dexamethasone. Clin Exp Pharmacol Physiol 2003;30:32-7.
5. Nyirenda MJ, Lindsay RS, Kenyon CJ, et al. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 1998;101:2174-81.
6. Celsi G, Kistner A, Aizman R, et al. Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring. Pediatr Res 1998;44:317-22.
7. Dodic M, Abouantoun T, O'Connor A, et al. Programming effects of short prenatal exposure to dexamethasone in sheep. Hypertension 2002;40:729-34.
8. Hofman PL, Regan F, Jackson WE, et al. Premature birth and later insulin resistance. N Engl J Med 2004;351:2179-86.
9. Keijzer-Veen MG, Finken MJ, Nauta J, et al. Is blood pressure increased 19 years after intrauterine growth restriction and preterm birth? A prospective follow-up study in The Netherlands. Pediatrics 2005;116:725-31.
10. Hovi P, Andersson S, Eriksson JG, et al. Glucose regulation in young adults with very low birth weight. N Engl J Med 2007;356:2053-63.
11. Kist-van Holthe, van Zwieten PH, Schell-Feith EA, et al. Is nephrocalcinosis in preterm neonates harmful for long-term blood pressure and renal function? Pediatrics 2007;119:468-75.
12. Doyle LW, Ford GW, Davis NM, et al. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci (Lond) 2000;98:137-42.
13. Seckl JR. Antenatal glucocorticoid therapy: a caveat to the applause. Clin Sci (Lond) 2000;98:127-8.
14. Dessens AB, Haas HS, Koppe JG. Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics 2000;105:E77.
15. Dalziel SR, Walker NK, Parag V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005;365:1856-62.
16. Verloove-Vanhorick SP, Verwey RA, Brand R, et al. Neonatal mortality risk in relation to gestational age and birthweight. Results of a national survey of preterm and very-low-birthweight infants in The Netherlands. Lancet 1986;1:55-7.
17. Weither FJ, den Ouden AL, Verloove-Vanhorick SP. Looking back in time: outcome of a national cohort of very preterm infants born in The Netherlands in 1983. Early Hum Dev 2000;59:175-91.
18. Schutte MF, Treffers PE, Koppe JG, et al. The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour. Br J Obstet Gynaecol 1980;87:127-31.
19. Keirse MJ. Obstetrical attitudes to glucocorticoid treatment for fetal lung maturation: time for a change? Eur J Obstet Gynecol Reprod Biol 1984;17:247-55.
20. Fredriks AM, van FJuuren S, Fekkes M, et al. Are age-related references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice? Eur J Pediatr 2005;164:216-22.
21. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
22. Gungor N, Saad R, Janosky J, et al. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 2004;144:47-55.
23. Conwell LS, Trost SG, Brown WJ, et al. Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 2004;27:314-19.
24. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
25. Fredriks AM, van Buuren S, Burgmeijer RJ, et al. Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 2000;47:316-23.
26. Fredriks AM, van Buuren S, Wit JM, et al. Body index measurements in 1996-7 compared with 1980. Arch Dis Child 2000;82:107-12.
27. Singh RR, Cullen-McEwen LA, Kett MM, et al. Prenatal corticosterone exposure results in altered AT1/AT2, nephron deficit and hypertension in the rat offspring. J Physiol 2007;579:502-13.
28. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet 2004;363:1728-31.
29. Kajantie E, Raivio T, Janne OA, et al. Circulating glucocorticoid bioactivity in the preterm newborn after antenatal betamethasone treatment. J Clin Endocrinol Metab 2004;89:3999-4003.
30. Verhaeghe J, van Bree R, van Herck E, et al. Exogenous corticosteroids and in utero oxygenation modulate indices of fetal insulin secretion. J Clin Endocrinol Metab 2005;90:3449-53.
31. Moise AA, Wearden ME, Kozinetz CA, et al. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics 1995;95:845-50.
32. Miall-Allen VM, de Vries LS, Whitelaw AG. Mean arterial blood pressure and neonatal cerebral lesions. Arch Dis Child 1987;62:1068-9.
33. Martens SE, Rijken M, Stoelhorst GM, et al. Is hypotension a major risk factor for neurological morbidity at term age in very preterm infants? Early Hum Dev 2003;75:79-89.
34. Boluyt N, van Kempen A, Offringa M. Neurodevelopment after neonatal hypoglycemia: a systematic review and design of an optimal future study. Pediatrics 2006;117:2231-43.
35. Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. Br Med J 1988;297:1304-8.